GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Northland Biotech Co Ltd (BJSE:430047) » Definitions » Additional Paid-In Capital

Beijing Northland Biotech Co (BJSE:430047) Additional Paid-In Capital : ¥0.00 Mil(As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Northland Biotech Co Additional Paid-In Capital?


Beijing Northland Biotech Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0.00 Mil) to Dec. 2023 (¥213.84 Mil) but then stayed the same from Dec. 2023 (¥213.84 Mil) to Mar. 2024 (¥0.00 Mil).

Beijing Northland Biotech Co's annual additional paid-in capital increased from Dec. 2021 (¥202.31 Mil) to Dec. 2022 (¥205.86 Mil) and increased from Dec. 2022 (¥205.86 Mil) to Dec. 2023 (¥213.84 Mil).


Beijing Northland Biotech Co Additional Paid-In Capital Historical Data

The historical data trend for Beijing Northland Biotech Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Northland Biotech Co Additional Paid-In Capital Chart

Beijing Northland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.94 192.40 202.31 205.86 213.84

Beijing Northland Biotech Co Quarterly Data
Mar19 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 213.84 - 213.84 -

Beijing Northland Biotech Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Beijing Northland Biotech Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Beijing Northland Biotech Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Northland Biotech Co (BJSE:430047) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Shangdi Kaikai Road, A406, Zhongguancun Biomedical Park, Haidian District, Beijing, CHN, 100085
Beijing Northland Biotech Co Ltd is a biopharmaceutical company specializing in the research and development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.

Beijing Northland Biotech Co (BJSE:430047) Headlines

No Headlines